Coetason Nasal Drops (Mometasone Furoate)

Adult use

1. Allergic Rhinitis Adults (including the elderly) and adolescents aged 12 and older: Generally, spray twice in each nostril once a day (total daily dose 0.2 mg). Once symptoms improve, the maintenance dose can be reduced to once in each nostril (total daily dose 0.1 mg). If symptoms do not improve, the dose can be increased up to 4 times in each nostril once a day (total daily dose 0.4 mg). 2. Nasal Polyps Generally, spray twice in each nostril once a day (total daily dose 0.2 mg). If symptoms do not improve after 5 to 6 weeks, the dose can be increased to twice daily spraying (total daily dose 0.4 mg), and if symptoms improve, the dose should be reduced. If no symptom improvement is seen after 5 to 6 weeks of twice-daily administration, other treatment methods should be considered. There are no studies on the use of this medication for more than 4 months for the treatment of nasal polyps. 3. Acute Rhinosinusitis Generally, spray twice in each nostril twice a day (total daily dose 0.4 mg).

Child use

Children aged 2 to 11 years: Generally, spray once in each nostril once a day (total daily dose 0.1 mg).

This medication should not be used in certain patients. It should be avoided in cases of allergies to this drug or its components, untreated infections of the nasal mucosa, recent nasal surgery or any nasal injuries, and in infants under 2 years of age. Additionally, caution is advised when used in patients with tuberculosis, systemic infections, ocular herpes, those who have frequent nosebleeds, patients at risk of exposure to chickenpox or measles, those with certain types of nasal polyps, pregnant or potentially pregnant women, and nursing mothers. When using this drug, side effects such as headache, nosebleed, cough, sore throat, and upper respiratory infection may occur. Rarely, serious allergic reactions like bronchospasm or anaphylaxis may occur, and if such symptoms occur, administration should be stopped immediately and medical assistance should be sought. Long-term use at high doses may lead to systemic side effects; caution is required, especially if symptoms of severe bacterial infection appear. Regular checks of the condition of the nasal mucosa should be performed during prolonged use, and if a local fungal infection develops, treatment should be stopped or appropriate treatment initiated. In children, there is a possibility of growth delay; therefore, growth should be monitored regularly during administration, and the drug should not be used in children under 2 years of age since safety has not been established. When used by pregnant or nursing mothers, the risks to the fetus or infant and the benefits of this drug must be carefully considered, and during pregnancy, adrenal function should be monitored closely. This drug may interact with other medications, especially when used with CYP3A4 inhibitors, increasing the risk of side effects, so caution is necessary. Before use, the container should be shaken well, and test spraying should be performed, ensuring that it is not sprayed directly into the eyes or onto the nasal septum. Keep out of reach of children, and effects on driving or operating machinery are not known.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, difficulty breathing or wheezing, asthma attack, respiratory issues accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis.

Mild side effects

Headache, viral infections, pharyngitis, nosebleed, cough, upper respiratory infection, menstrual pain, musculoskeletal pain, sinusitis, vomiting, arthralgia, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, indigestion, otalgia, cold symptoms, myalgia, nausea, rhinitis, diarrhea, inflammation of the nose, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itchiness, dryness, pain, redness, discomfort), throat symptoms (irritation, pain, discomfort, dryness.

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. The storage temperature should be between 2°C and 25°C, avoiding extremely hot or cold places.

Appearance

A white or almost white opaque suspension in a plastic container designed to deliver a metered spray.

Package unit

18 mL/bottle